Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment

JAMA Dermatol. 2016 Aug 1;152(8):944-5. doi: 10.1001/jamadermatol.2016.0866.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Dermatomyositis / diagnosis*
  • Dermatomyositis / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Resistance, Multiple
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Piperidines / administration & dosage*
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Pyrroles / administration & dosage*
  • Sampling Studies
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles
  • tofacitinib